Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Cardiopulmonary effects of antimalarial drugs

Identifieur interne : 003B97 ( Main/Exploration ); précédent : 003B96; suivant : 003B98

Cardiopulmonary effects of antimalarial drugs

Auteurs : Shigeru Matsuo [États-Unis] ; Ruy Ruiz [États-Unis] ; James Smith Jr. [États-Unis] ; Domingo M. Aviado [États-Unis]

Source :

RBID : ISTEX:E11FDD2F92641FFD2655369021FCDE2A15E6C4F6

English descriptors

Abstract

Abstract: WR 40,070 (5-piperonyl-2-4-diaminopyrimidines) was compared with trimethoprim in 4 animal species: mice, rats, rabbits, and dogs. The most important difference between the two compounds uncovered in our investigation is the nature of their cardiac effects. Trimethoprim caused a decrease in cardiac output in the anesthetized dogs whereas WR 40,070 caused an increase. The mechanism responsible for the difference was demonstrated in the dog heart-lung preparation. WR 40,070 caused an improvement in ventricular function by releasing catecholamines. The heart-lung prepared from a dog previously treated with reserpine did not show the cardiac stimulation characteristic of WR 40,070. The transmembrane potential recorded from the isolated rat atrial muscle revealed some changes which suggest that the anti-folic acid activity of this compound and pyrimethamine cause prolongation of repolarization time. The in vitro addition of folic acid caused further prolongation of repolarization time. These changes are not related to the primary changes in contractility and excitability brought about by diaminopyrimidines.

Url:
DOI: 10.1016/0041-008X(70)90138-9


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Cardiopulmonary effects of antimalarial drugs</title>
<author>
<name sortKey="Matsuo, Shigeru" sort="Matsuo, Shigeru" uniqKey="Matsuo S" first="Shigeru" last="Matsuo">Shigeru Matsuo</name>
</author>
<author>
<name sortKey="Ruiz, Ruy" sort="Ruiz, Ruy" uniqKey="Ruiz R" first="Ruy" last="Ruiz">Ruy Ruiz</name>
</author>
<author>
<name sortKey="Smith Jr, James" sort="Smith Jr, James" uniqKey="Smith Jr J" first="James" last="Smith Jr.">James Smith Jr.</name>
</author>
<author>
<name sortKey="Aviado, Domingo M" sort="Aviado, Domingo M" uniqKey="Aviado D" first="Domingo M." last="Aviado">Domingo M. Aviado</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E11FDD2F92641FFD2655369021FCDE2A15E6C4F6</idno>
<date when="1970" year="1970">1970</date>
<idno type="doi">10.1016/0041-008X(70)90138-9</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-JPT8SG7B-Z/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002299</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002299</idno>
<idno type="wicri:Area/Istex/Curation">002299</idno>
<idno type="wicri:Area/Istex/Checkpoint">002933</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002933</idno>
<idno type="wicri:doubleKey">0041-008X:1970:Matsuo S:cardiopulmonary:effects:of</idno>
<idno type="wicri:Area/Main/Merge">003C79</idno>
<idno type="wicri:Area/Main/Curation">003B97</idno>
<idno type="wicri:Area/Main/Exploration">003B97</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Cardiopulmonary effects of antimalarial drugs</title>
<author>
<name sortKey="Matsuo, Shigeru" sort="Matsuo, Shigeru" uniqKey="Matsuo S" first="Shigeru" last="Matsuo">Shigeru Matsuo</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Ruiz, Ruy" sort="Ruiz, Ruy" uniqKey="Ruiz R" first="Ruy" last="Ruiz">Ruy Ruiz</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Smith Jr, James" sort="Smith Jr, James" uniqKey="Smith Jr J" first="James" last="Smith Jr.">James Smith Jr.</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Aviado, Domingo M" sort="Aviado, Domingo M" uniqKey="Aviado D" first="Domingo M." last="Aviado">Domingo M. Aviado</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Toxicology and Applied Pharmacology</title>
<title level="j" type="abbrev">YTAAP</title>
<idno type="ISSN">0041-008X</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1970">1970</date>
<biblScope unit="volume">17</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="130">130</biblScope>
<biblScope unit="page" to="150">150</biblScope>
</imprint>
<idno type="ISSN">0041-008X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0041-008X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Action potentials</term>
<term>Anesthetized</term>
<term>Anesthetized dogs</term>
<term>Anesthetized rabbits</term>
<term>Antiarrhythmic</term>
<term>Antimalarial</term>
<term>Antimalarial drugs</term>
<term>Aortic</term>
<term>Aortic blood flow</term>
<term>Arterial blood pressure</term>
<term>Atria1</term>
<term>Atria1 muscle</term>
<term>Atria1 rate</term>
<term>Aviado</term>
<term>Cardiac</term>
<term>Cardiac effects</term>
<term>Cardiac output</term>
<term>Catecholamine</term>
<term>Contractile force</term>
<term>Control injection</term>
<term>Cycle length</term>
<term>Depolarization</term>
<term>Depolarization time</term>
<term>Diaminopyrimidines</term>
<term>Folic</term>
<term>Folic acid</term>
<term>Folk acid</term>
<term>Further prolongation</term>
<term>Heart rate</term>
<term>Infusion</term>
<term>Inhalation</term>
<term>Next group</term>
<term>Organ bath</term>
<term>Pharmacol</term>
<term>Pretreatment</term>
<term>Prolongation</term>
<term>Pulmonary resistance</term>
<term>Pyrimethamine</term>
<term>Rats pretreated</term>
<term>Repolarization</term>
<term>Repolarization time</term>
<term>Reserpine</term>
<term>Subcutaneously</term>
<term>Transmembrane</term>
<term>Trimethoprim</term>
<term>Ventricular</term>
<term>Ventricular function</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: WR 40,070 (5-piperonyl-2-4-diaminopyrimidines) was compared with trimethoprim in 4 animal species: mice, rats, rabbits, and dogs. The most important difference between the two compounds uncovered in our investigation is the nature of their cardiac effects. Trimethoprim caused a decrease in cardiac output in the anesthetized dogs whereas WR 40,070 caused an increase. The mechanism responsible for the difference was demonstrated in the dog heart-lung preparation. WR 40,070 caused an improvement in ventricular function by releasing catecholamines. The heart-lung prepared from a dog previously treated with reserpine did not show the cardiac stimulation characteristic of WR 40,070. The transmembrane potential recorded from the isolated rat atrial muscle revealed some changes which suggest that the anti-folic acid activity of this compound and pyrimethamine cause prolongation of repolarization time. The in vitro addition of folic acid caused further prolongation of repolarization time. These changes are not related to the primary changes in contractility and excitability brought about by diaminopyrimidines.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Pennsylvanie</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Pennsylvanie">
<name sortKey="Matsuo, Shigeru" sort="Matsuo, Shigeru" uniqKey="Matsuo S" first="Shigeru" last="Matsuo">Shigeru Matsuo</name>
</region>
<name sortKey="Aviado, Domingo M" sort="Aviado, Domingo M" uniqKey="Aviado D" first="Domingo M." last="Aviado">Domingo M. Aviado</name>
<name sortKey="Ruiz, Ruy" sort="Ruiz, Ruy" uniqKey="Ruiz R" first="Ruy" last="Ruiz">Ruy Ruiz</name>
<name sortKey="Smith Jr, James" sort="Smith Jr, James" uniqKey="Smith Jr J" first="James" last="Smith Jr.">James Smith Jr.</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B97 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003B97 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:E11FDD2F92641FFD2655369021FCDE2A15E6C4F6
   |texte=   Cardiopulmonary effects of antimalarial drugs
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021